Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: DiaGenic CEO Christensen Resigns; NanoString Taps Beecham as SVP of R&D


DiaGenic said this week that CEO Erik Christensen has resigned.

Christensen will "continue to provide consultative support to the company on partner interactions, licensing and other business activities," DiaGenic said in a statement.

Henrik Lund, chairman of the company's board, will serve as CEO until a replacement for Christensen is found. Ingrid Wiik, deputy chairman of the board, will act as chairman until the company's annual general meeting on June 5.

Christensen has been CEO of DiaGenic since 2007.

NanoString Technologies has appointed Joseph Beechem as senior vice president of research and development.

Beechem joins the company from Life Technologies, where he was most recently vice president; head of advanced sequencing; and head of global sequencing chemistry, biochemistry, and biophysics. Prior to that, he was chief technology officer of Life Technologies, chief scientific officer at Invitrogen (now part of Life Tech), and director of biosciences at Molecular Probes.

Prior to joining industry, Beechem was an associate professor at Vanderbilt University for 11 years. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.